Timothy J Brown Selected Research

Timothy J Brown Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 06/2013
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 03/2022 - 01/2017
1	Weight Loss (Weight Reduction) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Cachexia 10/2021
1	Cancer Pain 11/2020
1	Opioid-Induced Constipation 11/2020
1	Lung Neoplasms (Lung Cancer) 11/2020
1	Mucositis 01/2020
1	Mast-Cell Sarcoma 12/2019
1	Glioma (Gliomas) 07/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 05/2019
1	Myositis (Idiopathic Inflammatory Myopathies) 04/2019
1	Tumor Lysis Syndrome 01/2019
1	Pneumonia (Pneumonitis) 12/2018
1	Hemoptysis 12/2018
1	Fever (Fevers) 12/2018
1	Insulinoma 01/2018
1	Inflammation (Inflammations) 01/2018
1	Adenocarcinoma 01/2017
1	Carcinoma (Carcinomatosis) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Leukemia 01/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 11/2016
1	Embolism (Embolus) 05/2016
1	Craniosynostoses (Craniosynostosis) 01/2016
1	Pathologic Constriction (Stenosis) 01/2016
1	Congenital Diaphragmatic Hernias 01/2016
1	Anorectal Malformations 01/2016
1	Congenital Abnormalities (Deformity) 01/2016
1	Congenital Microtia 01/2016
1	Ovarian Neoplasms (Ovarian Cancer) 06/2013
1	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 05/2008
1	Tuberculosis (Tuberculoses) 05/2008

Drug/Important Bio-Agent (IBA)

2	CeramidesIBA 10/2019 - 01/2018
2	Therapeutic UsesIBA 08/2018 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2017 - 05/2008
1	Sorafenib (BAY 43-9006)FDA Link 03/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	entinostat (MS 275)IBA 01/2022
1	regorafenibIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2021
1	MegestrolIBA 10/2021
1	Opioid Analgesics (Opioids)IBA 11/2020
1	LaxativesIBA 11/2020
1	SphingolipidsIBA 10/2019
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 07/2019
1	Oxidoreductases (Dehydrogenase)IBA 04/2019
1	rasburicase (Elitek)FDA Link 01/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2018
1	Azithromycin (Zithromax)FDA LinkGeneric 12/2018
1	pasireotideIBA 01/2018
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	Dasatinib (BMS 354825)FDA Link 01/2017
1	Epidermal Growth Factor (EGF)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	tirbanibulinIBA 01/2017
1	OrganophosphatesIBA 01/2016
1	avermectinIBA 01/2016
1	Pyrethrins (Pyrethroids)FDA Link 01/2016
1	CopperIBA 01/2016
1	CarbamatesIBA 01/2016
1	TriazinesIBA 01/2016
1	EstersIBA 01/2016
1	Petroleum (Crude Oil)IBA 01/2016
1	oxyfluorofenIBA 01/2016
1	ORALIT (ORS)IBA 01/2016
1	EthersIBA 01/2016
1	PesticidesIBA 01/2016
1	AcidsIBA 01/2016
1	NeonicotinoidsIBA 01/2016
1	di-beta-(morpholinoethyl)selenide (MOSE)IBA 06/2013
1	Glucose (Dextrose)FDA LinkGeneric 06/2013
1	SphingosineIBA 06/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2013

Therapy/Procedure

8	Therapeutics 03/2022 - 05/2016
3	Drug Therapy (Chemotherapy) 01/2020 - 05/2019
1	Radiotherapy 01/2020
1	Liver Transplantation 01/2017
1	Photopheresis 01/2017